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and lysophosphatidylethanolamine. Regarding fatty acid 
composition, a significant increase of n-7 fatty acids was 
observed in amastigotes. Overall, the total n-6 fatty acids 
were decreased in PL. Several of the changes were also 
observed in TG and free fatty acids. Particularly, n-7 fatty 
acids and 20:4n-6 were highly increased, whereas n-9 fatty 
acid and n-6 precursors decreased.
Keywords Leishmania donovani complex · Amastigotes · 
Lipid variations · Cholesterol · Fatty acids · Phospholipids
Abbreviations
Ama  Amastigote
BSTFA  Bis(trimethylsilyl) trifluoroacetamide
FA  Fatty acid
FAME  Fatty acid methyl esters
CerPCho  Sphingomyelin
C  Total cholesterol
ERG  Ergosterol
GC  Gas chromatography
HILIC  Hydrophilic interaction liquid chromatography
LPtdCho  Lysophosphatidylcholine
LPtdEtn  Lysophosphatidylethanolamine
MbCD  Methyl-b-cyclodextrin
PBS  Phosphate-buffered saline 
PL  Phospholipids
PLFA  Phospholipid fatty acid
Pro  Promastigote
PtdCho  Phosphatidylcholine
PtdEtn  Phosphatidylethanolamine
PtdIns  Phosphatidylinositol
PtdSer  Phosphatidylserine
SEM  Standard error of the mean
TG  Triglycerides
VL  Visceral leishmaniasis
Abstract Leishmania sp., are trypanosomatid parasites 
that are phagocytized by human and animal macrophages. 
Transformation from the vector promastigote stage to the 
intracellular amastigote host cell stage is mandatory, since 
development in the host depends on the internalization of 
the parasite. We identified and analyzed the lipids involved 
in the promastigote to amastigote transformation process 
in the Leishmania donovani complex. Four lipid classes, 
phospholipids, free fatty acids, triglycerides and sterols 
were studied. The derivatization method of Bligh and Dyer 
was used to establish the fatty acid composition in each 
stage of the parasite. To stay within the context of Leish-
mania infection, we used amastigotes extracted from mac-
rophages after experimental in vitro infection. The purifi-
cation process was checked by electronic microscopy, the 
absence of major contamination by host-cell debris and a 
correct purification yield validated our experimental model. 
Our results show that free fatty acids and cholesterol 
increased, whereas triglycerides and ergosterol decreased 
during the transition between promastigotes to amas-
tigotes. With respect to phospholipid classes, we found 
increased proportion of sphingomyelin and phosphati-
dylserine and lowered proportion of phosphatidylinositol 
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Introduction
Leishmania donovani and L. infantum are the causative 
agents of visceral leishmaniasis (VL) in humans and of 
canine leishmaniasis in dogs. Leishmania is an intracellu-
lar pathogen, whose establishment depends on its success-
ful internalization and multiplication inside macrophages, 
its mammalian host cell. The Leishmania life cycle is 
divided into two phases, each of them involving a differ-
ent stage, the promastigote stage in the insect vector and 
the amastigote stage inside the host’s macrophages. The 
promastigotes inoculated during the blood meal of the 
hematophagous sandfly are phagocytosed by endocytosis 
and undergo a transformation into amastigotes within a 
parasitophorous vacuole of phagolysosomal origin. This 
process is a vital step in the Leishmania life cycle and 
could be pivotal in the research for new treatments against 
Leishmania.
To date, studies have essentially focused on the role of 
surface glycosylated residues and proteins in host-parasite 
interactions. Recent interest has grown for the role of lipids 
in Trypanosomatids and especially in Trypanosoma cruzi, 
T. brucei and Leishmania spp. [1]. Lipid metabolism is 
of paramount importance for parasites, and especially for 
intracellular parasites, which rely on a complex system 
of uptake and synthesis mechanisms to satisfy their lipid 
needs.
The parameters of this system change dramatically as the 
parasite transits through the various stages of its life cycle. 
Within host cells, intracellular pathogens often develop in 
specialized vacuoles and the flow of lipids between host 
and pathogen-controlled membranous compartments is 
pivotal to the pathogen’s ultimate success [2–4]. Intracel-
lular pathogens have evolved sophisticated mechanisms 
to manipulate and tap into the lipid metabolism of their 
host cells. These include interference with vesicular and 
non-vesicular cellular lipid trafficking in viral [5], bacte-
rial [6] and protozoal [7] pathogens. According to Zhang 
and Beverley [8], phospholipids (PL) and sphingolipids 
are both abundant and critical to virulence and viability in 
Leishmania. The success of miltefosine as an orally avail-
able antileishmanial drug is an important validation of lipid 
metabolism as a drug target. Moreover, it has been previ-
ously reported that macrophage cholesterol is important for 
parasite internalization. The entry of intracellular parasites 
and particularly of Leishmania, involves interaction with 
the plasma membrane of host cells. A number of previous 
studies have demonstrated the requirement of membrane 
cholesterol in host-pathogen interactions [9, 10]. Choles-
terol (C) is an important component of higher eukaryotic 
cellular membranes and plays a crucial role in the function 
and the organization of membrane proteins and receptors 
[11, 12], some of which being necessary for parasite entry 
[4].
Our goal was to analyze the variations in major lipid 
classes during the metamorphosis from the promastigote to 
the amastigote stage, in terms of quantities and fatty acid 
composition. Biological membranes are composed of fatty 
acids (FA) and phospholipids, which are present in constant 
proportions, but when exposed to some stress conditions, 
such as pathogens or drugs, these proportions might change 
[13]. The identification of these specific variations could be 
used as biomarkers to study virulence or resistance to treat-
ments currently used against leishmaniasis.
Materials and Methods
Promastigote Culture
The strains used in this study were L. donovani and L. 
infantum that both belong to the Leishmania donovani 
complex. Leishmania donovani (LCR-133) was provided 
from the Leishmania Reference Center, Jerusalem, Israel 
and the L infantum strain was isolated in Spain from an 
infected dog. The promastigotes were grown at 22 °C in 
TC-199 medium (GE Healthcare, Pasching, Austria) sup-
plemented with 20% fetal bovine serum and 2% antibiot-
ics (streptomycin and penicillin, GE Healthcare, Pasching, 
Austria). The parasites were cultured in 75-cm2 culture 
flasks and were isolated during their exponential growth 
phase by centrifugation at 1300×g for 15 min. The flasks 
containing the parasites were washed 3 times with 10 ml 
PBS and before lipid analysis, a total protein assay was 
performed with the Bradford method.
Macrophage Culture
The BALB/c mice cell line J774A.1 (European Collec-
tion of Cell Cultures) were maintained at 37 °C with 5% 
CO2 by successive passages in RPMI-1640 culture medium 
(PAA) containing 10% (v/v) fetal bovine serum (Sigma, St-
Quentin Fallavier, France), 1% MycoKill AB (GE health-
care, Pasching, Austria) and 1.5% Penicillin/Streptomycin 
(PAA, GE Healthcare, Pasching, Austria).
Infection of Macrophages and Isolation of Amastigotes
The macrophages from five 75-cm2 flasks were infected at 
a ratio of 10 parasites per cell. After 72 h, the infected cells 
were collected by trypsinization, centrifuged at 300×g for 
5 min and then suspended in PBS. The infected cells were 
disrupted by repeated passaging—at least 30—through 
a syringe fitted with a 22-gauge needle (Sigma-Aldrich, 
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St-Quentin Fallavier, France). To facilitate the process, the 
cells were weakened by one freeze–thaw cycle at −80 °C. 
Several centrifugations at 300×g for 5 min were performed 
to eliminate host-cells debris. The amastigote-containing 
suspension was then filtered through a 3-µm polycarbon-
ate membrane (Merck, Molsheim, France) to remove the 
remaining host-cell debris. The purified amastigotes were 
concentrated by centrifugation at 2000×g for 10 min.
The infected macrophages were Giemsa-stained, the 
intracellular amastigotes were counted, and after isola-
tion from macrophages, the number of isolated amastig-
otes was evaluated, after Giemsa staining, to calculate the 
purification yield. Various parameters, such as the number 
of freeze–thaw cycles and the number of disruption cycles 
were optimized to improve the purification yield.
For each sample, a total protein assay was performed 
with the Bradford method and 1 mg of total extract was 
used for lipid analysis.
Transmission Electron Microscopy (TEM)
Axenic and purified intracellular amastigotes were fixed 
with 4% glutaraldehyde in 0.2 M cacodylate buffer, pH 7.4, 
post-fixed with 1% osmium tetroxide and 0.8% potassium 
ferrocyanide in 0.1 M cacodylate buffer, dehydrated in a 
graded series of acetone and embedded in Epon. Ultrathin 
sections were stained with uranyl acetate and lead citrate 
and observed under a Jeol 1400 JEM transmission electron 
microscope (Tokyo, Japan) set at 120 kV.
Lipid Analyses
Total phospholipids, triglycerides and free fatty acids
Total lipids were extracted from cell lysates (0.1% Triton 
in water) by the method of Bligh and Dyer [14] after addi-
tion of butylated hydroxytoluene (BHT, 50 µM final) as 
an antioxidant. PC17:0, 17:0, TG17:0 (Sigma, St-Quentin 
Fallavier, France), were added to serve as internal stand-
ards. Lipids were separated on thin layer chromatography 
(silica gel 60 plates, Merck, Fontenay sous Bois, France) 
using the solvent system hexane/diethylether/acetic acid 
80:20:1 (v/v), revealed under UV light after spraying 
0.05% 2′7′-dichlorofluorescein (Sigma) in methanol and 
identified by comparison with an authentic standard spot-
ted on the same plate. Phospholipids, free fatty acids and 
triglycerides (TG) spots were scrapped from the plate and 
transmethylated using boron trifluoride (Sigma, St-Quentin 
Fallavier, France). The resulting fatty acid methyl esters 
(FAME) were analyzed by GC using a Hewlett-Packard 
system equipped with a Supelco SP2380 capillary column 
(60 m × 0.22 mm) with helium as a carrier gas. FAME 
were identified by comparison with commercial standards 
[15]. Results are expressed as molar percentage of each 
individual fatty acid calculated from the sum of all detected 
fatty acids taken as 100%. Quantification of PL, TG and 
free FA pools was made in correspondence with their fatty 
acid content using the internal standards.
Sterols
Lipid standards (cholesterol, epicoprostanol and ergos-
terol) and chemicals of the highest grade available were 
purchased from Sigma Aldrich (St-Quentin Fallavier, 
France). Mass spectrometry quality grade solvents were 
purchased from Fischer Scientific (Illkirch, France). Total 
lipids were extracted from cell pellets (1 mg) according to 
the method of Bligh and Dyer [14]. Organic phases corre-
sponding to 100 µg of extract were evaporated to dryness 
under vacuum. Dried lipids were hydrolyzed for 45 min 
at 56 °C with potassium hydroxide 10 M in ethanol con-
taining 2 µg of epicoprostanol used as internal standard. 
Sterols were extracted by hexane and water. After evapora-
tion, sterols were derivatized with 100 µL of a mixture of 
bis(trimethylsilyl)trifluoroacetamide/trimethylchlorosilane 
4/1 v/v for 1 h at 80 °C. Sterols, derivatized as trimethylsi-
lyl-ethers, were analyzed by GCMS in a 7890A Gas chro-
matograph connected to a 5975C Mass Selective Detec-
tor (Agilent Technologies). Separation was achieved on a 
HP-5MS 30 m × 250 µm column (Agilent Technologies) 
using helium as carrier gas. The MSD was set up as fol-
low: EI at 70 eV mode, source temperature at 230 °C. Data 
were acquired in SIM mode using 363.3, 368.3 and 370.3 
quantitation ions (m/z) for ergosterol, cholesterol and epi-
coprostanol respectively. A calibration curve was obtained 
with cholesterol (1–8 µg) and ergosterol (1–16 µg) stand-
ards using the same method used for samples.
Phospholipids Analysis
Phospholipids (PL) were first separated by liquid chroma-
tography under HILIC conditions and then detected by a 
Corona™ ultra RS Charged Aerosol Detector™ (CCAD, 
Thermo Scientific, USA). High performance liquid chro-
matography was performed using a Dionex UltiMate™ 
3000 LC pump from Thermo Scientific (USA) equipped 
with a dual-gradient pump which allows a post-separation 
inverse gradient approach to compensate solvent gradient 
effects in CCAD detection. Separation of PtdCho, PtdEtn, 
PtdIns, PtdSer, CerPCho, LPtdCho, and LPtdEtn stand-
ards was achieved under HILIC conditions using a Thermo 
Accucore column (150 × 2.1 mm, 2.6 µm, Hilic, Thermo 
Scientific, USA). The mobile phase consisted of a gradient 
of (A) ACN/H2O (95:5, v/v) and (B) ACN/H2O (50:50, v/v) 
containing 10 mM ammonium acetate. The flow rate was 
at 800 µL·min−1. The injection volume was 5 µL and the 
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column was maintained at 40 °C. Eluate from the HPLC 
system was introduced in a CCAD for detection of the 
phospholipids. The liquid chromatography and the CCAD 
were controlled by Chromeleon 7.2 (Thermo Scientific 
Dionex).
Results
Purification of Amastigotes
After standardization of our intra-macrophagic amastigotes 
purification method, the best results were obtained after 18 
cycles of passaging of the cells by a Hamilton syringe, and 
after a short freezing—1 h—of the infected macrophages. 
The purification yield of amastigotes recovered from 
freeze-thawed cells (87.2%) was higher than when the cells 
were directly processed (45.6%). The purification process 
was monitored by optical (results not shown) and electron 
microscopy that showed that the intramacrophagic amas-
tigotes obtained by our purification method had a regular 
shape and were in overall good condition. Electron micros-
copy also evidenced the absence of contamination by host-
cell material at the end of the purification process (Fig. 1).
Lipid Profiles
Independent cultures of L. donovani and L. infantum were 
prepared and processed for lipid analyses.
We first determined the lipid distribution of major lipid 
classes (total PL, TG, free FA and sterols) in both parasite 
forms in order to highlight specific changes during differen-
tiation of promastigote to amastigotes (Fig. 2). Both Leish-
mania species showed similar changes. Among the major 
differences in amastigotes compared to promastigotes was 
the marked increase of the free fatty acid pools by about 
2-fold. By contrast, the PL content was decreased nearly by 
half without reaching statistical significance and TG were 
reduced by 85% percent. Regarding sterols, as expected, 
promastigote forms contained more ergosterol than cho-
lesterol with an ergosterol/cholesterol ratio of about 2.5 
(ergosterol 210 ± 18 nmol/mg protein and 355 ± 23 nmol/
mg protein in L. donovani and L. infantum, respectively; 
cholesterol 83 ± 7 nmol/mg protein and 143 ± 21 nmol/
mg protein in L. donovani and L. infantum, respectively). 
Of interest, the cholesterol content in amastigotes increased 
by nearly 2-fold in both species, whereas that of ergosterol 
decreased by about 80%, so that the ergosterol/cholesterol 
ratio lowered to less than 0.25.
Figure 3 shows the PL profiles. Again, very close data 
were found for both Leishmania species. In promastig-
otes, the predominant PL were PtdCho, PtdEtn and LPt-
dEtn. PtdIns, PtdSer, CerPCho and LPtdCho were found 
in much lower proportion. Other PL such as cardiolipin, 
Fig. 1  Electron microscopy of purified intracellular and axenic 
Leishmania amastigotes. a purified intracellular amastigotes of L. 
donovani, b purified intracellular amastigotes of L. infantum, the 
presence of vacuoles (V) in purified amastigotes could be explained 
by the observed cholesterol increase. F flagellum, K kinetoplast, N 
nucleus, M mitochondrion, FP flagellar pocket, C cytoskeleton
Fig. 2  Lipid modifications in amastigotes. Lipid quantification was 
made by GC as detailed in materials and methods. The bars represent 
the ratio amastigote/promastigote for lipid quantities calculated as 
nmol/mg protein. Data are the means ± SD of 3 independent deter-
minations. PL phospholipids, TG triacylglycerols, FA free fatty acids, 
C cholesterol, ERG ergosterol. *p ≤ 0.05, **p ≤ 0.01, significant dif-
ferences between promastigote and amastigote by t test
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phosphatidylglycerol and phosphatidic acid were not 
detected or at only trace amounts. Among the major 
changes in amastigotes were the marked increase of Cer-
PCho and PtdSer. Conversely, LPtdEtn and PtdIns were 
significantly decreased. There was no change for major PL, 
PtdCho and PtdEtn.
Fatty Acid Composition
Tables 1 and 2 show the fatty acid composition of major 
lipids, total phospholipids and triacylglycerols as well as 
free fatty acid profiles. Similar observations could be made 
for both Leishmania species.
PL from promastigotes contained primarily saturated 
and monounsaturated fatty acids whereas n-6 fatty acids 
were prominent in TG. For both lipids, n-6 fatty acids 
were found in much higher proportion than n-3 fatty 
acids, with n-6/n-3 ratios of 13.6 and 9.1 in PL and TG, 
respectively. Noticeably, both lipids showed high propor-
tions of 18:2n-6/18:3n-6 and low proportion of 20:4n-
6. The opposite was observed for n-3 fatty acids with 
higher proportions of the elongation/desaturation products 
22:5n-3/22:6n-3 as compared to their 18C precursors (not 
detected). One may also notice that the distribution of fatty 
acids in the unesterified pool was very close to that of TG, 
which may suggest metabolic links for TG deacylation/
reacylation pathway.
Important changes were observed in amastigotes 
(Tables 1, 2). Regarding PL, the monounsaturated fatty acid 
content was modified with a significant increase of n-7 fatty 
acids at the expense of 18:1n-9. Overall, the total n-6 fatty 
acids were decreased in PL. However, the proportion of 
20:4n-6 was significantly increased by 5-fold, whereas the 
precursors 18:2 and 18:3n-6 were decreased. Conversely, 
n-3 fatty acids were increased, especially the end product 
22:6n-3. These changes are reflected by a 5-fold higher n-3/
n-6 ratio. Several of the changes are also observed in TG 
and free fatty acids. Especially, n-7 fatty acids and 20:4n-6 
were highly increased, whereas n-9 fatty acid and n-6 pre-
cursors were decreased. In contrast to PL, no major changes 
were observed for n-3 fatty acids in TG and free fatty acids.
Table 3 summarizes these changes expressed as amastig-
ote/promastigote ratios for the major lipid classes.
Discussion
The main objective of this study was to highlight major 
changes between promastigote and amastigote stages in 
terms of lipid distribution and fatty acid composition. We 
chose to purify the amastigotes from their host cells rather 
than to use in vitro axenic amastigotes, in order to mimic 
physiological conditions of the parasite life cycle, i.e. the 
internalization of the promastigotes by the macrophages 
and their subsequent transformation and multiplication. In 
this respect, our purification method provided an efficient 
yield and electronic microscopy showed a normal morphol-
ogy of the purified amastigotes even if some of them suf-
fered from the purification process.
With respect to lipid distribution, the hallmark of dif-
ferentiation of promastigotes into amastigotes is the sig-
nificant change of the cholesterol/PL ratio consequent to 
the 2-fold increase of cholesterol content and moderate 
decrease of PL content. This may result in major changes 
in surface membrane composition, although intracellular 
accumulation of cholesterol in the parasitophorous and 
in the cytoplasmic vacuoles cannot be excluded (Fig. 1). 
Regarding that host membrane cholesterol has been shown 
to be required for leishmanial infection based on choles-
terol depletion with cyclodextrins [16], one may hypoth-
esize that amastigote cholesterol originates from host mem-
brane cholesterol. Recently, Yao and Wilson [17], showed 
that the sterol content of Leishmania promastigotes varies 
according to the changes in the culture medium and to all 
the changes that occur during metacyclogenesis. According 
to these authors these variations are due to the adsorption 
of cholesterol from the environment and at the same time 
to a decrease in the synthesis of ergosterol by the parasite.
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Fig. 3  PL distribution in promastigote and amastigote. Lipid quanti-
fication was made by HPLC-CAD as detailed in materials and meth-
ods. The bars represent the % of total PL. Data are the means ± SD 
of four independent determinations. PtdCho phosphatidylcholine, 
PtdEtn phosphatidylethanolamine, PtdIns phosphatidylinositol, 
PtdSer phosphatidylserine, CerPCho Sphingomyelin, LPtdCho 
lysophosphatidylcholine, LPtdEtn lysophosphatidylethanolamine. 
*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 significant differences between 
promastigote
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A similar mechanism may be involved during differ-
entiation from promastigote to amastigote. Our data also 
revealed a significant increase of the free fatty acid pool 
that may result from PL and TG hydrolysis.
The important role of cholesterol in the pathogenic-
ity of visceral leishmaniasis has been widely studied and 
confirmed. Ghosh et al. in 2011 [18] found that a decrease 
in the serum cholesterol content of patients with VL was 
inversely proportional to the parasitic load in the spleen. 
In 2014, in another work, Ghosh et al. [19] reported that 
a decline in the level of membrane cholesterol during the 
infection by Leishmania disrupted membrane rafts.
Studies performed on hypercholesterolemic mice 
showed that the cholesterol level was directly related to 
the severity of disease progression [20]. Ghosh et al. [21] 
reported the requirement of host membrane cholesterol in 
the binding and internalization of L. donovani into mac-
rophages using complementary approaches. They showed 
that treatment of macrophages in culture with the cho-
lesterol carrier methyl ß-cyclodextrin (MbCD) resulted 
in specific removal of membrane cholesterol, and a con-
comitant reduction in binding and subsequent infection by 
Leishmania promastigotes [22]. We also observed a similar 
increase in cholesterol in axenic amastigotes, compared to 
promastigotes (results not shown) and studies on its origin 
and its role in ergosterol synthesis are currently under way.
In agreement with previous reports for several Leishma-
nia species, including L. donovani [8, 23–25], the major PL 
in L. donovani and L. infantum promastigotes were found 
to be PtdCho and PtdEtn. Our results are also consistent 
with the literature with respect to lower content of PtdIns, 
PtdSer and no or only trace amounts of cardiolipin, phos-
phatidylglycerol and phosphatidic acid. The low propor-
tion of CerPCho has also been reported, consistent with 
the fact that Leishmania parasites do not synthesize this 
lipid [8]. This suggests that amastigotes in which CerPCho 
was found in high proportion acquire this lipid from host 
cells. Interestingly, it was previously shown that the para-
site could degrade CerPCho from host cells to increase its 
virulence [26]. The increase in PS in amastigotes may be 
related to studies indicating that in Leishmania, PS expo-
sure may play a role in parasite apoptosis and the patho-
genicity of leishmaniasis [8].
Fatty acid analyses of promastigote lipids from the two 
Leishmania species indicate higher proportions of unsatu-
rated fatty acids (up to 6 unsaturations) compared to satu-
rated ones. In PL, TG and free fatty acid pools, C18 fatty 
acids were predominant, including both saturated, mono 
Table 1  Fatty acid composition 
of total phospholipids, 
triacylglycerols and free fatty 
acid profile in L. infantum 
promastigote and amastigote
Fatty acid composition was determined by GC analysis as described in materials and methods. Data, 
expressed as mole percent, are means of 3 independent experiments ± SD
* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 significant differences between promastigote and amastigote by t 
test
Phospholipids Triacylglycerols Free fatty acids
Pro Ama Pro Ama Pro Ama
14:0 0.4 ± 0.3 3.2 ± 0.3* 2.2 ± 0.7 2.8 ± 0.7 1.5 ± 1.2 5.7 ± 1.2**
16:0 21.3 ± 3.2 28.4 ± 0.9 5.8 ± 0.6 10.8 ± 0.8** 6.4 ± 1.5 28.3 ± 4.0***
18:0 8.5 ± 1.0 10.3 ± 1.3 10.8 ± 1.2 10.4 ± 1.6 14.4 ± 3.8 10.7 ± 0.9
Total saturate 30.2 41.9 18.8 24.0 22.3 44.7
16:1n-9 0.7 ± 0.2 0.7 ± 0.1 1.3 ± 0.3 3.7 ± 0.6* 0.3 ± 0.1 0.9 ± 0.2**
16:1n-7 0.6 ± 0.1 6.4 ± 0.9** 0.4 ± 0.2 3.8 ± 0.7** 1.2 ± 0.2 5.3 ± 1.2**
18:1n-9 34.9 ± 4.5 20.8 ± 1.1* 25.5 ± 1.5 24.5 ± 0.9 21.8 ± 3.2 17.1 ± 4.1
18:1n-7 2.8 ± 0.7 16.1 ± 2.3** 2.1 ± 0.6 10.7 ± 2.8* 2.7 ± 0.9 17.4 ± 3.0***
Total monoenoic 39.1 44.0 29.3 42.7 26.0 40.7
18:2n-6 11.2 ± 2.9 3.3 ± 0.9* 10.9 ± 2.1 6.6 ± 0.2* 15.6 ± 3.8 4.6 ± 1.1**
18:3n-6 12.4 ± 2.7 0.7 ± 0.3** 32.6 ± 0.9 19.0 ± 2.4*** 29.1 ± 5.0 2.4 ± 1.9***
20:3n-6 4.5 ± 1.1 2.3 ± 0.2 3.5 ± 0.9 2.4 ± 1.2 3.6 ± 0.9 2.3 ± 0.8
20:4n-6 0.8 ± 0.1 3.1 ± 0.8* 0.3 ± 0.1 1.5 ± 0.1** 0.4 ± 0.1 2.4 ± 1.4*
Total n-6 28.9 9.4 47.3 29.5 48.7 11.7
18:3n-3 nd nd nd nd nd nd
20:5n-3 nd 0.5 ± 0.3* nd nd nd nd
22:5n-3 1.3 ± 0.2 1.9 ± 0.5 1.6 ± 0.5 1.7 ± 0.1 1.2 ± 0.7 1.4 ± 0.6
22:6n-3 0.7 ± 0.1 2.3 ± 1.1 3.0 ± 0.6 2.1 ± 0.9 1.8 ± 0.6 1.5 ± 0.6
Total n-3 1.8 4.7 4.6 3.8 3.0 2.9
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Table 2  Fatty acid composition 
of total phospholipids, 
triacylglycerols and free fatty 
acid profile in L. donovani 
promastigote and amastigote
Fatty acid composition was determined by GC analysis as described in materials and methods. Data, 
expressed as mole percent, are means of 3 independent experiments ± SD
* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 significant differences between promastigote and amastigote by t 
test
Phospholipids Triacylglycerols Free fatty acids
Pro Ama Pro Ama Pro Ama
14:0 0.6 ± 0.3 3.0 ± 0.5** 2.6 ± 0.8 4.0 ± 1.5 1.9 ± 0.7 4.0 ± 1.5
16:0 23.5 ± 3.2 26.5 ± 4.4 3.9 ± 0.9 10.5 ± 1.0** 6.9 ± 0.6 23.3 ± 0.9**
18:0 10.0 ± 1.7 9.7 ± 1.3 10.6 ± 1.2 10.0 ± 2.2 13.4 ± 1.9 13.0 ± 2.5
Total saturate 34.1 39.2 17.1 24.5 22.2 40.3
16:1n-9 0.5 ± 0.3 0.9 ± 0.3 1.5 ± 0.8 3.4 ± 0.7* 0.5 ± 0.2 1.2 ± 0.5
16:1n-7 0.7 ± 0.3 8.0 ± 0.8*** 0.5 ± 0.2 4.1 ± 0.8** 1.3 ± 0.5 7.0 ± 2.4*
18:1n-9 35.9 ± 2.1 20.1 ± 0.2*** 29.6 ± 3.4 22.1 ± 3.6 20.2 ± 3.7 19.3 ± 0.6
18:1n-7 3.3 ± 1.1 18.3 ± 2.3*** 1.6 ± 0.2 13.8 ± 4.0* 2.6 ± 1.0 20.5 ± 4.3**
Total monoenoic 40.4 47.3 33.2 43.4 24.6 48.0
18:2n-6 9.5 ± 1.2 3.4 ± 1.0* 8.6 ± 2.5 6.4 ± 1.0 13.4 ± 1.7 3.7 ± 1.4*
18:3n-6 10.6 ± 3.0 0.6 ± 0.3** 31.8 ± 1.5 15.3 ± 2.4*** 31.3 ± 3.8 1.3 ± 1.0***
20:3n-6 3.1 ± 1.4 1.5 ± 0.5 3.5 ± 0.9 3.5 ± 0.1 4.6 ± 0.2 1.1 ± 0.5*
20:4n-6 0.7 ± 0.2 3.5 ± 1.0** 0.3 ± 0.1 2.1 ± 0.8* 0.5 ± 0.1 2.3 ± 0.8*
Total n-6 23.9 9.3 44.2 27.3 49.5 8.4
18:3n-3 nd nd nd nd nd nd
20:5n-3 nd 0.7 ± 0.3* nd nd nd nd
22:5n-3 1.1 ± 0.9 1.6 ± 0.4 1.9 ± 0.3 1.9 ± 0.1 1.4 ± 0.9 1.7 ± 0.2
22:6n-3 0.5 ± 0.1 1.7 ± 0.6 3.6 ± 0.8 2.9 ± 0.3 2.0 ± 0.8 1.6 ± 0.1
Total n-3 1.6 4.2 5.5 4.8 3.4 3.3
Table 3  Fatty acid change 
ratios in major lipids
Values represent the ratios Amastigote/Promastigote
Phospholipids Triacylglycerols Free fatty acids
L. infantum L. donovani L. infantum L. donovani L. infantum L. donovani
Saturated
14:0 8.0 5.0 1.3 1.5 3.8 2.1
16:0 1.3 1.1 1.8 2.7 4.4 3.4
18:0 1.2 1.0 1.0 0.9 0.7 1.0
Monounsaturated
16:1n-9 1.0 1.8 2.8 2.3 3.0 2.4
16:1n-7 10.7 11.4 9.5 8.2 4.4 5.4
18:1n-9 0.6 0.6 1.0 0.7 0.8 1.0
18:1n-7 5.8 5.5 5.1 8.6 6.4 7.9
n-6 polyunsaturated
18:2n-6 0.3 0.4 0.6 0.7 0.3 0.3
18:3n-6 0.1 0.1 0.6 0.5 0.1 0.1
20:3n-6 0.5 0.5 0.7 1.0 0.6 0.2
20:4n-6 3.9 5.0 5.0 7.0 6.0 4.6
n-3 polyunsaturated
22:5n-3 1.5 1.5 1.1 1.0 1.2 1.2
22:6n-3 3.3 3.4 0.7 0.8 0.8 0.8
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and polyunsaturated ones. The long chain polyunsaturated 
fatty acids arachidonic and docosahexaenoic acids were 
found in low proportions. Overall, these observations are 
consistent with previous reports on lipid fatty acid compo-
sition in various Leishmania species [13, 23, 24, 27, 28]. 
Yet, several differences were noticeable, especially the 
absence of 18:3n-3 in all analyzed lipids, whereas this fatty 
acid was previously reported to be abundant in phosphati-
dylcholine from Leishmania promastigotes [24], but only 
minor in total phospholipids according to another study 
[29]. Moreover, other fatty acids reported before in lipids 
from Leishmania are not listed in the present data, as they 
were in low proportion and were not changed upon the dif-
ferentiation process [13, 30]. Our data show a predomi-
nance of n-6 fatty acids in total PL. Of note, according to 
Adosraku et al. [25] distribution may vary among PL class, 
since they reported that PE is highly enriched in n-6 fatty 
acids whereas PC contains more n-3 fatty acids. Beach et 
al. [30] reported high content of docosahexaenoic acid in 
diphosphatidylglycerol. It has been previously proposed 
that these differences could be due to culture conditions, 
the age of the culture and the origin of the Leishmania 
strains [25].
Previous studies reported that both ∆6 and ∆5 elongases 
and ∆6, ∆5 and ∆4 desaturases were expressed in Leish-
mania major for the complete pathway of polyunsaturated 
fatty acid biosynthesis [1, 31]. Accordingly, both n-3 and 
n-6 elongation/desaturation products were detected in both 
L. donovani and L. infantum.
In promastigotes, n-6 fatty acids were present in a much 
higher proportion than n-3 fatty acids regardless of the lipid 
class, with a n-3/n-6 ratio between 0.07 and 0.10. Of note, 
in all lipid classes, the end-product 20:4n-6 was minor 
compared to the precursors 18:2 and 18:3n-6. Although 
∆5 and ∆4 desaturases have been identified in Leishmania 
species, no 22C-n-6 fatty acids were detected. The oppo-
site was observed for n-3 fatty acids, with the recovery of 
the end products 22:5n-3 and 22:6n-3, whereas the 18C and 
20C-precursors were not detected. Interestingly, 22:6n-3 
was found in equal or higher proportion than 20:4n-6 
which is different from the plasma of their mammalian 
hosts, suggesting that these parasites closely regulate their 
FA composition.
Among the changes observed in amastigotes are the 
increase in total saturated and monounsaturated fatty acids 
and the decrease in total n-6 fatty acids regardless of the 
lipid class. The increase of saturated fatty acids is due to 
the specific increase of 16:0 for saturated FA, 18:1n-7 
for monounsaturated FA and 20:4n-6 for n-6 FA. Con-
versely, n-6 precursors 18:2 and 18:3n-6 were specifically 
decreased. Of note, the fatty acid lipid composition is 
close to that of host cells (not shown), suggesting that the 
remodeling of lipids in amastigotes depends on fatty acids 
and/or on desaturase/elongase activities that are available 
in macrophages. The increase in 20:4n-6 may also sug-
gest that these enzymes could be more efficient in amas-
tigotes than in promastigotes, although long-chain n-3 fatty 
acids were not increased. It would be of interest to study 
the oxygenated fatty acid metabolism in Leishmania since 
eicosanoids derived from 20:4n-6 are well known to exert 
many biological activities in mammalian cells. Mi-Ichi et 
al. [32] reported that serum-derived fatty acids are essential 
for the intraerythrocytic proliferation of Plasmodium falci-
parum in humans. They showed that combinations of pal-
mitic acid (16:0)/oleic acid (18:1 n-9), palmitic acid (16:0)/
vaccenic acid (18:1 n-7), or stearic acid (18:0), promoted 
the intraerythrocytic parasite growth and they confirmed 
the importance of 16:0 and 18:1 n-9 during the erythrocytic 
cycle. Thus, 18:1 n-9 is mandatory for the intraerythrocytic 
proliferation of P. falciparum. Phospholipids are believed 
to be critical to virulence and viability in Leishmania [8]. 
As components of phospholipids and glycosylphosphati-
dylinositol anchors, fatty acids are responsible for forming 
the core of biological membranes and the correct locali-
zation of proteins within membranes [1]. The high phos-
phorylation dynamics during promastigote to amastigote 
differentiation [33] also suggests that protein phosphoryla-
tion cascades are involved in the developmental regulation 
of Leishmania parasites. Fatty acids can be used as energy 
sources and serve as signalling molecules or precursors for 
their synthesis. They also contribute to the anchoring of 
proteins by direct acylation of specific amino acids.
Our intracellular amastigotes model, together with the 
use of axenic amastigotes as an alternative model is useful 
for studying the host-cell infection by Leishmania. Since 
it is closer to the reality of the host-parasite interactions, 
it will help to elucidate the relationships between the host 
cholesterol and the parasite’s ergosterol and especially the 
role of cholesterol in both the transformation process and 
the sterol metabolism of Leishmania. Among the changes 
observed in amastigotes are the increase in total saturated 
and monounsaturated fatty acids and the decrease in total 
n-6 fatty acids, regardless of the lipid class. These changes 
might be of interest to study the specific role of some fatty 
acids in the virulence of Leishmania.
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